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Abstract: Plant-derived compounds and other natural substances are a rich potential source of 
compounds that kill or attenuate pathogens that are resistant to current antibiotics. Medieval so-
cieties used a range of these natural substances to treat conditions clearly recognizable to the 
modern eye as microbial infections, and there has been much debate over the likely efficacy of 
these treatments. Our interdisciplinary team, comprising researchers from both sciences and hu-
manities, identified and reconstructed a potential remedy for Staphylococcus aureus infection 
from a 10th Century Anglo-Saxon Leechbook. The remedy repeatedly killed established S. aure-
us biofilms in an in vitro model of soft tissue infection and killed methicillin-resistance S. aureus 
(MRSA) in a mouse chronic wound model. While the remedy contained several ingredients that 
are individually known to have some antibacterial activity, full efficacy required the combined 
action of several ingredients, highlighting the scholarship of pre-modern doctors and the poten-
tial of ancient texts as a source of new antimicrobial agents.  
 
 
Importance: While the antibiotic potential of some materials used in historical medicine has 
been demonstrated, empirical tests of entire remedies are scarce. This is an important omission, 
because the efficacy of “ancientbiotics” could rely on the combined activity of their various in-
gredients. This would lead us to underestimate their efficacy and, by extension, the scholarship 
of pre-modern doctors. It could also help us to understand why some natural compounds that 
show antibacterial promise in the laboratory fail to yield positive results in clinical trials. We 
have reconstructed a 1,000-year-old “antibiotic” which kills the bacteria it was designed to treat, 
and shown that this activity relies on combined activity of several antimicrobial ingredients. Our 
results highlight (a) the scholarship and rational methodology of pre-modern medical profession-
als and (b) the untapped potential of pre-modern remedies for yielding novel therapeutics at a 
time when new antibiotics are desperately needed. 
 
  
  
 
 
Introduction  
Antibiotic resistance is a clear and present danger to human health, and there are worryingly few 
new antibiotics in the developmental pipeline (1). A rich source of new antimicrobials potentially 
resides in medieval and early modern medical texts: microbial infection has been a constant 
presence throughout human history, and manuscript evidence shows that early modern and pre-
modern societies used a range of natural compounds to treat conditions that are clearly recog-
nizable as microbial infections. Some substances used in pre-modern treatments for infection 
(e.g. extracts from garlic (2-5)), show antimicrobial or virulence-reducing effects under certain 
conditions, but experiments that test the antibiotic activities of entire historical remedies are few 
and far between. This is an important omission, because the efficacy of these “ancientbiotics” 
could rely on the combined activity of their various ingredients. This would lead us to underes-
timate their efficacy and, by extension, the scholarship of pre-modern doctors. It could also help 
to explain why in vitro antibacterial activity of individual compounds does not always reliably 
translate into in vivo antimicrobial potential (e.g. garlic, (6)). 
 
Bald’s Leechbook (7) (Materials & Methods), is an English medical text from the Anglo-Saxon 
period. The manuscript was written in the 10th Century and contains remedies for various ail-
ments, including clearly recognizable microbial infections. Medieval medicine has generally 
been dismissed as backwards or superstitious, but recent scholars have suggested that among the 
remedies there may be methods and recipes that indicate a more factual application (8-10). One 
of Bald’s remedies, a salve for a ‘wen’ or lump in the eye (Fig. 1), is particularly interesting to 
the modern microbiologist. It aims to treat a condition caused by bacterial infection, and contains 
ingredients with the potential for antimicrobial activity. The recipe instructs the reader to crush 
garlic and a second Allium species (whose translation into modern English is ambiguous), com-
bine these with wine and oxgall (bovine bile), and leave the mixture to stand in a brass or bronze 
vessel for nine days and nights.  
 
The ‘wen’ is most likely a stye: an infection of an eyelash follicle. Today, most styes are caused 
by the Gram-positive bacterium Staphylococcus aureus (11), which also causes other severe and 
persistent infections of various tissues. The spread of methicillin-resistant (MRSA) strains has 
exacerbated this problem (11, 12). MRSA is particularly associated with chronic wound infec-
tions, which affect increasing numbers of people and are often highly resistant to treatment (11, 
13). 
 
The ingredients combined to treat this infection appear promising to the modern microbiologist.  
Allium species produce a range of antimicrobial compounds (3).  Ajoene, which is found in gar-
lic (A. sativum), and allicin (found in garlic, ramsons (A. ursinum) and spring onions (A. fistu-
losum), may prevent biofilm formation by S. aureus and other bacterial species (4) and interfere 
with quorum sensing and virulence in Pseudomonas aeruginosa (5). Other antimicrobial com-
pounds produced by Allium species include flavonoids such as quercetin, kaempferol and their 
derivatives, found in leek (A. ampeloprasum / A. porrum) and onion (A. cepa) (3), and the anti-
microbial peptide Ace-AMP1, so far only characterized in onion (14). Bile may also be antibac-
terial: it is generally thought to limit bacterial overgrowth in the host small intestine (15). Wine 
  
may act as a source of plant-derived antimicrobial small molecules or simply as a solvent for the 
extraction of compounds from the plant matter in the recipe. Finally, it is possible that copper 
salts may leach from the vessel in which the eyesalve is prepared. Copper surfaces prevent bacte-
rial growth (16) and host-derived copper plays a role in immune defense (17).  Interestingly, 
there is evidence that Allium-derived compounds may act synergistically with other antimicrobial 
agents, including copper (18) and tobramycin (2, 5).  
 
We therefore sought to test the effect of Bald’s eyesalve on S. aureus, and to determine whether 
any antibacterial activity could be attributed to a single ingredient, or was reliant on combining 
the ingredients according to the instructions laid down by ‘Bald’. 
 
 
Results 
 
Reconstruction of Bald’s eyesalve 
We reconstructed four independent batches of the recipe (A-D, see Materials & Methods). For 
each batch, we made two variants of the recipe, one using onion (ES-O) and one using leek (ES-
L) for the ambiguous Allium sp. We chose these because they both produce antimicrobial flavo-
noids that are not found in garlic, and onion also produces an antimicrobial peptide (3, 19). We 
also made preparations of the individual ingredients at approximately the same concentrations as 
they are found in the recipe (Batches A,B), versions of the recipe with single ingredients omitted 
(Batch C), and a version of the recipe which was tested before and after the nine-day waiting pe-
riod (Batch D). All of these were prepared in glass bottles, to which we added squares of brass 
sheet to simulate the brass/bronze vessel. The complete recipes were a clear, slightly acidic (pH 
4.6-4.7) brownish liquid. The full recipes were apparently self-sterilizing: we cultured bacteria 
from aliquots of the leek and oxgall preparations, but not from aliquots of ES-O or ES-L (Data 
S1).  
  
Bald’s eyesalve kills planktonic and biofilm cultures of S. aureus 
As shown in Fig. 2A, both ES-O and ES-L prevented growth of planktonic cultures of S. aureus 
growing aerobically at 37°C in synthetic wound fluid (SWF, (20)). Aliquots of cultures were 
plated out at the end of the incubation period and no colonies observed (detection limit: 30 colo-
ny-forming units). Further, 5 µl of each culture was transferred to 1 ml fresh SWF and incubated 
overnight at 37°C but no growth was observed, showing that Bald’s eyesalve was bactericidal, 
rather than simply bacteriostatic, in these conditions.  
 
However, during infection, bacteria often exist as dense, antibiotic-resistant biofilms in a matrix 
of self-excreted polysaccharides and soft tissue from the host (11, 13, 21). We therefore grew S. 
aureus for 24 hours at 37°C in a synthetic model of soft tissue infection comprising SWF solidi-
fied with collagen (20). We exposed the resulting mature biofilms to batches A and B of ES-O or 
ES-L, or preparations of the individual ingredients, for a further 24 hours (Fig. 2B). A general-
ized linear model revealed a significant effect of treatment (χ27 1.5e+10, p < 0.001): post-hoc 
Tukey tests showed that only ES-O and ES-L were significantly different from the control treat-
ment (p < 0.001), causing marked reductions in the number of viable cells recovered from syn-
thetic wounds. None of the individual ingredients alone had a significant effect on viable cell 
counts. There was also a significant effect of batch (χ21 4.2e+9, p < 0.001) and a significant in-
  
teraction between batch and treatment (χ27 2.0e+9, p < 0.001): this was because the full recipes 
from batch B were slightly more bactericidal than batch A, and the effects of the individual in-
gredient preparations differed between batches. The full recipes retained bactericidal activity af-
ter thirty days of storage at 4°C (Fig. S1).  
 
Bald’s eyesalve is only effective when the recipe is followed carefully 
We then made a third batch (C) of ES-O and ES-L, along with variants in which individual in-
gredients were systematically omitted. These were tested against S. aureus in the synthetic 
wound biofilm model. A generalized linear model revealed a significant effect of treatment (χ211 
3.1e+9, p < 0.001). We used Dunnett’s Test to test contrasts of interest. First, we contrasted each 
recipe with the control. Both ES-O and ES-L caused a significant reduction in viable cell num-
bers (t21 = 6.38, p < 0.001; t21 = 6.25, p < 0.001); this was comparable to results for batches A 
and B (Fig. 3). When onion/leek was dropped from the common recipe base, partial bactericidal 
activity was still observed (t21 = 3.38, p = 0.015). Bactericidal activity was also retained when 
brass or oxgall was dropped from either ES-O (t21 = 6.00, p < 0.001; t21 = 3.80, p = 0.005) or ES-
L (t21 = 7.08, p < 0.001; t21 = 5.38, p < 0.001). Dropping either garlic or wine from ES-O or ES-L 
completely removed bactericidal activity: viable cell counts were not significantly different form 
the control (p ≥ 0.166). We then compared the modified recipes that retained bactericidal activity 
with their parent recipes. The bactericidal power of the common recipe base when onion/leek 
was omitted was significantly impaired compared with either ES-O or ES-L (t6 = 9.307, p = 
0.005 and t6 = 18.2, p < 0.001, respectively). Omitting brass from either ES-O or ES-L had no 
effect on their bactericidal activities (t10 = 0.684, p = 0.897 and t10 = 0.685, p = 0.896, respective-
ly. Omitting oxgall decreased the bactericidal activity of ES-O (t10 = 4.66, p = 0.001) but not ES-
L (t10 = 0.710, p = 0.885). 
 
The combination of garlic, wine and the other Allium species thus appears crucial for the full ef-
ficacy of Bald’s eyesalve and, when onion is used in place of leek, oxgall is also necessary for 
full activity. Brass may be dispensable, but it is possible that its presence may facilitate activity 
against other bacterial species; additionally, using a brass pot may have allowed the Anglo-
Saxon physician to start work with an uncontaminated vessel, as the copper content could pre-
vent bacteria colonizing its surface. 
 
Batch D of Bald’s eyesalve was used to test whether the nine-day waiting period was important. 
ES-O and ES-L, with a water control, were tested in the synthetic wound biofilm model (a) im-
mediately after preparation and (b) after nine days (Fig. 4). ANOVA revealed significant effects 
of treatment (F2,24 = 110.9, p < 0.001), time (immediate/after nine days; F1,24 = 410.2, p < 0.001) 
and their interaction (F2,24 = 44.3, p < 0.001). Post-hoc Tukey tests showed that while both fresh 
and nine-day-old ES-O and ES-L killed cells (comparisons vs. respective control, p ≤ 0.037), the 
number of viable cells left after treatment with either version of the eyesalve was lower when the 
eyesalve had been left to stand for nine days prior to use (both p < 0.001). ES-O and ES-L 
caused a two-log drop in viable S. aureus cells if used immediately after preparation, but a four- 
to five-log drop if used after nine days (Fig. 4, consistent with data in Fig. 2B, Fig. 3).  
 
 
Bald’s eyesalve kills MRSA in chronically-infected animal tissue  
  
All the ingredients in Bald’s eyesalve are edible, and the likelihood of copper accumulating to 
levels toxic to mammalian cells seems low. Therefore, we tested its efficacy against S. aureus in 
a mouse model of chronic wound infection (22) using a thoroughly modern pathogen: methicil-
lin-resistant S. aureus (MRSA) (12). Mice were administered wounds as previously described 
(22) and infected with MRSA. Four days post-infection, wounds were excised and submerged in 
ES-O, ES-L (Batch B), sterile saline or the clinical last-line antibiotic vancomycin (100 µg ml-1) 
for four hours. As shown in Fig. 5, vancomycin did not cause significant reductions in viable 
bacteria during this relatively very short exposure time (contrast of least-squares mean adjusted 
for experimental block; t16 = 1.45, p = 0.491). However, ES-O and ES-L caused statistically sig-
nificant drops in the numbers of viable cells recovered from wounds (approximately tenfold re-
duction; t16 = 3.94, p = 0.006 and t16 = 3.66, p = 0.010 respectively).. Batches A and B of ES-O 
and ES-L were also tested in the mouse wound model after three months of storage at 4°C, but 
without the vancomycin comparison (Fig. S2): in this experiment, ES-L, but not ES-O, caused a 
statistically significant drop in the numbers of viable cells recovered from wounds (approximate-
ly tenfold reduction). Thus, while there is some inter-batch variability in activity, Bald’s eyesalve 
shows potential as an anti-Staphylococcal agent in vivo.  
 
 
 
Discussion 
 
In summary, we have reconstituted a 1,000-year-old remedy for bacterial infection and shown 
that it kills the most common cause of the infection it was designed to treat. Bald’s eyesalve 
eliminates S. aureus in planktonic culture and reduces viable cell numbers by several orders of 
magnitude in a synthetic model of established biofilm infection. This effect depends upon the 
combination of several ingredients and upon the nine-day storage period specified in the recipe. 
Further, a highly antibiotic resistant strain of S. aureus, MRSA, is susceptible to Bald’s eyesalve 
when infected tissue from a mouse chronic wound model is exposed to the recipe. In this model, 
significant bactericidal activity was observed after a brief period of exposure during which the 
current last-line clinical antibiotic (vancomycin) does not kill significant numbers of bacteria. 
Our findings contrast with a previous attempt to test Bald’s eyesalve by Brennessel et al., (23), 
who found it ineffective against S. aureus in disk diffusion assays; however, these authors did 
not specify the methods of preparation and do not give quantitative results nor details of replica-
tion, so we do not know exactly how their tests were conducted. 
 
Future work will explore the mechanism(s) by which  Bald’s eyesalve kills S. aureus. We note 
that several of the ingredients may damage biological membranes. Bile salts act as surfactants 
(15), the Ace-AMP1 antimicrobial peptide present in onion is thought to have lipid-binding ac-
tivity (19), and saponins (present in a wide variety of Allium spp. can bind sterols present in bio-
logical membranes (3). Other antimicrobial compounds present in Allium spp. have been shown 
to act as enzyme inhibitors (allicin and flavonoids: (3)). Wine may be a source of further plant-
derived antimicrobial small molecules, or it may simply act as a solvent for the extraction of 
compounds from the other ingredients in the recipe – with the nine-day waiting period providing 
time for molecule extraction. 
 
  
It is interesting that copper was entirely dispensable for anti-Staphylococcal activity in our syn-
thetic wound model. Copper has been shown to have broad-spectrum antibacterial activity (16, 
17) and we would expect copper salts to accumulate in our preparations: we observed copper 
compounds forming on the surface of the brass squares used to simulate the preparation vessel, 
and Brennessel et al (who used an actual brass pot), found that copper salts accumulated to high 
levels in their version of Bald’s eyesalve (M Drout, personal communication). It is possible that 
we simply did not have a large enough copper surface to allow copper to accumulate to biologi-
cally active levels in our recipe. Alternatively, the copper vessel itself may have allowed the An-
glo-Saxon physician to begin their work with an uncontaminated pot due to the resistance of 
copper surfaces to bacterial colonization. A third possibility is that copper is entirely dispensable: 
copper alloy bowls of the Anglo-Saxon period can be highly decorated (even inlaid with silver) 
and appear as grave goods in high status burials as a marker of feasting power (24), and perhaps 
the more humble vessels may have been a marker of the physician’s professional status.  
 
 
The combined activity of molecules derived from the different ingredients might explain why the 
activity of Bald’s eyesalve is greater than the sum of its parts: the mixture may attack the bacte-
ria on several fronts. This is an important consideration for future work on natural antimicrobial 
compounds, as strong in vitro activity of individual compounds has not always translated into 
positive in vivo results (6). Alternatively, novel compounds may be formed as molecules from 
different ingredients react over the nine-day storage period specified by the recipe. Future re-
search into antibiotics derived from natural materials would benefit from considering potential 
combinatorial activity of different ingredients, and pre-modern medical texts provide an excel-
lent starting point for this strategy. Such work will require extensive collaborative research in-
volving historians, linguists, microbiologists and analytical/medicinal chemists.  
 
When we describe Bald’s eyesalve as being “designed” to treat eye infection, we do not use the 
term lightly. There has been considerable debate about levels of scholarship and scientific meth-
od among early medieval medical practitioners (8, 9, 25). This may be partly due because of an 
almost complete absence of theoretical material, and the fact that the surviving corpus of  Anglo-
Saxon medicine seems to be compilations of excerpts and treatises (26). Further, many recipes - 
such as the getting a virgin to get water from an eastwards-flowing spring for a cyst ‘which pains 
the heart’ from the mid-eleventh century Lacnunga - look rather dubious as a remedy. Medicine, 
as some scholars have claimed, was a craft and not a science in early medieval Europe (26), and 
there was a lack of explanatory frameworks. Texts, such as Bald’s Leechbook, were most likely 
composed in a monastic environment, and in many text sources there is a conflation of spiritual 
and practical healing. More credence has been given to later medieval texts, associated with the 
School of Salerno and the growth of university-based training (27).  
 
However, our finding that the combination of ingredients used is crucial for bactericidal activity 
supports the hypothesis that this “ancientbiotic” was systematically constructed based on empiri-
cal knowledge. The fact that Anglo-Saxon recipes do not state detailed amounts of each compo-
nent requires the practitioners to have had some knowledge about how much of each ingredient 
to use. It is also notable that numerous ‘alternative’ recipes are often given for a condition – in-
dicating that a trained physician could adapt treatments when necessary. If medieval physicians 
really did use observation and experience to design effective antimicrobial medicines, then this 
  
predates the generally accepted date for the adoption of a rational scientific method (formation of 
the Royal Society in the mid 17th century) and the modern age of antibacterial medicine (Lister’s 
use of carbolic acid in the late 19th century) by several hundred years. 
 
 
 
 
 
 
 
  
  
 
 
 
 
Materials and Methods 
Bacterial strains and culture conditions. We used a standard laboratory wild-type strain of S. 
aureus (Newman) for initial in vitro tests of antibacterial activity. For the mouse chronic wound 
model, we used S. aureus Mu50 (ATCC number: 700699). Synthetic wound fluid (50% w/v fetal 
bovine serum, 50% peptone water, (20)) was used as the growth medium for all experiments. All 
cultures were grown aerobically at 37°C.  
 
Bald’s eyesalve. The recipe (Fig. 1) calls for equal amounts (“begea emfela”) of the Allium spe-
cies and equal amounts of wine and oxgall, but it is not clear whether these two pairs of quanti-
ties are equal to each other, nor whether ingredients were measured by weight or volume. We 
decided to combine equal amounts by volume of all of the recipe ingredients. For the complete 
eyesalve recipes, 25 ml peeled, finely-chopped garlic bulb was mixed with either 25 ml peeled, 
finely-chopped yellow onion or 25 ml finely-chopped leek (leaves) and these ingredients were 
crushed with a mortar and pestle for two minutes (the recipe asks for it to be pounded well: 
“gecnuwe wel tosomne”). Vegetables were purchased fresh from a greengrocer. 25 ml wine 
(Pennard Organic Wines) was added to the crushed alliums; we used an organic English white 
wine produced by a vineyard situated seven miles from the village of Panborough in Somerset: a 
charter of AD956 tells us that the Anglo-Saxon monastery of St Mary’s Abbey in Glastonbury 
held land rights to a vineyard at Panborough (28). We then added 25ml bovine bile salts (Fluka / 
Sigma Aldrich) dissolved in water at a concentration of 87mg ml-1; this is the natural concentra-
tion of bile salts in the bovine gall bladder (source: Sigma Aldrich technical support). The mix-
ture of alliums, wine and oxgall was placed in a sterile 250 ml Duran bottle and, following the 
reasoning of Brennessel et al. (23), nine clean and sterile 15 mm squares of 0.51 mm brass 260 
sheet (Hypertriton Inc, Canada) were added to the bottle to simulate the copper alloy vessel 
(“arfæt”). The lid was closed and the bottle wrapped in foil (as the original vessel would not 
have been transparent and we did not know if any ingredients were light sensitive). The recipes, 
denoted ES-O for the version containing onion and ES-L for the version containing leek, were 
then left refrigerated at 4°C for nine days. While the Anglo-Saxons did not have refrigerators, 
neither did they have centrally-heated buildings: we reasoned that the daily fluctuations in ambi-
ent temperature in the lab caused by heating during working hours were probably less realistic 
than a constant cool temperature. 
 
To test the antibacterial effects of the individual ingredients of the recipe, when we made batches 
A and B we also combined 6 ml of each ingredient (vegetables were finely chopped and crushed 
as described above) with 17 ml distilled water in a foil-wrapped glass bottle containing two 15 
mm squares of the brass sheet and left at 4°C for nine days. This is an approximately scaled-
down version of the recipe given the constraints imposed by measuring chopped vegetables ac-
curately and by requiring a whole number of brass squares. To provide a control treatment, 23 ml 
distilled water and two 15 mm squares of the brass sheet were left at 4°C for nine days.  
 
We repeated the preparation of full recipes and individual ingredients twice, using fresh ingredi-
ents each time, to produce two independent batches of the eyesalve/individual ingredient prepa-
  
rations (A and B). We later repeated the preparation a third time (batch C), making complete ES-
O and ES-L recipes, plus versions of the recipes that were each missing one ingredient, using the 
scaled-down, 24 ml total volume that was used for the individual ingredient preparations for 
batches A and B.  
  
The recipe calls for the mixture to be strained and “purified well” (“hlyttre wel”) before use or 
further storage. We debated how to simulate this and whether we should sterilize the mixtures. 
We decided that any microbes present in the ingredients are part of the “natural” state of the 
medicine and would not have been removed by filtering through cloth (probably linen). There-
fore, we briefly centrifuged each recipe/ingredient to pellet the solid material, and filtered the 
remaining liquid through a filter small enough to remove solid particles of vegetable matter, but 
large enough to let bacterial cells through (5 µm). Because the oxgall does not fully dissolve in 
the mixture, the finished eyesalve contains a fine white precipitate (especially noticeable when 
taken directly from cold storage). All versions of the eyesalve or its ingredients were thus briefly 
vortexed before use to ensure a homogenous suspension.  
 
Batch D of the complete recipes was made as above but in two sub-batches from the same ingre-
dients. One sub-batch was made without brass, shaken for ten seconds and then filtered and used 
in experiments immediately. Brass was added to the other sub-batch and this was stored for nine 
days at 4°C following the original recipe. 
 
Growth and testing of planktonic cultures in synthetic wound fluid. Cultures of S. aureus 
were grown for 6 hours (mid-log phase) in SWF at 37°C on an orbital shaker and 200 µl aliquots 
of this culture (containing 104-105 cells) were transferred to twelve wells of a 96-well microtitre 
plate. 100 µl sterile distilled water, ES-O or ES-L (Batch A only) were added to four wells each. 
Cultures were incubated at 37°C in a microplate spectrophotometer (Tecan Infinite) for 18 hours 
with periodic shaking; every 15 minutes the cultures were shaken for a few seconds and the 
OD600 of each well was measured. Because the eyesalve recipes were colored, we standardised 
the OD readings by subtracting the OD for each well at time = zero. 
 
Culturing and treatment of synthetic wound infections. S. aureus was streaked onto LB agar 
and incubated aerobically at 37°C for 24 hours. Multiple colonies were pooled to inoculate start-
er cultures in SWF. These were incubated aerobically at 37°C on an orbital shaker for 6 hours. 
Cultures were then diluted to an OD600 of 0.05 in SWF and 100 µl added to wells of 24-well cell 
culture plates containing synthetic wound medium. Synthetic wounds comprised 400 µl polymer-
ized collagen (2 mg ml-1 collagen, 0.01% acetic acid, 60% v/v SWF, 0.01 M sodium hydroxide). 
For experiments on Batches A and B of the eyesalve, additional synthetic wounds were mock-
inoculated with 100 µl sterile distilled water instead of S. aureus to reveal any growth of bacteria 
resident in the eyesalve or its component ingredients. Synthetic wounds were incubated aerobi-
cally at 37°C for 24 hours to allow establishment of bacterial biofilms within the collagen ma-
trix.  
 
Batches A and B of the full recipes and individual ingredient preparations were tested as follows. 
For S. aureus-infected wounds and the no-infection control, five replica synthetic wounds were 
overlaid with 200 µl of each complete recipe or individual ingredients. A further five infected 
and non-infected synthetic wounds were overlaid with 200µl sterile distilled water to provide 
  
mock-treated controls. Treated synthetic wounds were then incubated aerobically at 37°C for 24 
hours. The collagen was then depolymerized by treating each wound with 500 µl 0.5 mg ml-1 
collagenase. An aliquot of each wound was serially diluted and plated on LB agar to enumerate 
the number of viable cells present. 
 
For batch C (full recipes and recipes missing a single ingredient), this experiment was repeated 
but each preparation was tested in triplicate. For Batch D (full recipes before and after nine days 
storage), each preparation was tested in five replica wounds. For batches C and D, only a single 
no-infection control wound was used for each experiment; this was visually inspected to confirm 
the absence of contaminating bacterial growth and not analyzed further. 
 
Mouse chronic wound infections. Adult female, Swiss Webster mice were administered 
wounds as previously described (22) and infected with approximately 105 CFU S. aureus Mu50. 
At four days post-infection, mice were euthanized and their wound tissue was extracted and cut 
into 3 equal pieces, which were weighed. Wound sections were then submerged in 300 µl sterile 
saline, ES-O or ES-L for 4 hours, after which they were rinsed in sterile saline and homogenized. 
Wound homogenates were then serially diluted and plated on Mueller Hinton Agar with 4% 
NaCl and 6 µg/mL oxacillin (MRSA Screen Agar) to determine CFU/g tissue. This study was 
carried out in strict accordance with the recommendations in the Guide for the Care and Use of 
Laboratory Animals of the National Institutes of Health. The protocol was approved by the Insti-
tutional Animal Care and Use Committee of Texas Tech University Health Sciences Center (Pro-
tocol Number: 07044) and an NC3Rs ARRIVE checklist (29) is available for this work (Data 
S2). 
 
Statistical analyses. All data were analyzed with R (version 2.14.0 (R Foundation for Statistical 
Computing, http://www.R-project.org). Different models and their residuals were explored to 
find the most appropriate analysis for each data set. The S. aureus synthetic wound growth data 
sets for batches A-C of the recipes/ingredients were highly skewed; therefore, these data sets 
were analyzed using Generalized Linear Models with Poisson error. ANOVAs of log-
transformed data were used to analyze (a) the 30-day re-test of batches A and B in synthetic 
wound infections; and (b) the test for an effect of the nine-day waiting period using batch D. In 
all analyses where both batches A and B were used, we tested for effects of treatment, batch and 
their interaction. Post-hoc comparisons were conducted using the multcomp package (30). For 
the S. aureus synthetic wound data for batch C, one replica wound treated with eyesalve minus 
onion/leek had to be dropped from the data set as it completely dried out during incubation. Data 
on MRSA viable cell counts in mouse chronic wounds were not suitable for analysis using  gen-
eral linear models and so were analyzed by fitting least squares means for each treatment adjust-
ed for the effect of experimental block; Tukey tests were then used to test pairwise differences 
between treatments, with p-values adjusted for multiple comparisons. Growth curves of the S. 
aureus reporter strains were compared using the compare GrowthCurves function of the statmod 
package (version 1.4.21. http://CRAN.R-project.org/package=statmod). For each strain, growth 
curves from different treatments were compared using 1,000 permutations of the data and the 
Holm-Bonferroni correction for multiple comparisons.    
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Figure legends 
 
Figure 1. Bald’s eyesalve. A facsimile of the recipe, taken from the manuscript known as Bald’s 
Leechbook (London, British Library, Royal 12, D xvii). The original text reads as follows. “Ƿyrc 
eaȝsealf ƿiþ ƿænne: ȝenim cropleac 7 ȝarleac beȝea emfela, ȝecnuƿe ƿel tosomne, ȝenim ƿin 7 
fearres ȝeallen beȝean emfela ȝemenȝ ƿiþ þy leaces, do þonne on arfæt læt standan niȝon niht on 
þæm arfæt aƿrinȝ þurh claþ 7 hlyttre ƿel, do on horn 7 ymb niht do mid feþre on eaȝe; se betsta 
læcedom.” This is translated into modern English as follows. “Make an eyesalve against a wen: 
take equal amounts of cropleac [an Allium species] and  garlic,  pound well together, take equal 
amounts of wine and oxgall, mix with the Alliums, put this in a brass vessel, let [the mixture] 
stand for nine nights in the brass vessel, wring through a cloth and clarify well, put in a horn and 
at night apply to the eye with a feather; the best medicine.” 
 
Figure 2. Bald's eyesalve kills S. aureus in planktonic culture and in a synthetic wound biofilm 
model. (A) 100 µl of sterile distilled water (black lines), the onion variant of the eyesalve (ES-O, 
red lines) or the leek variant of the eyesalve (ES-L, blue lines) (both from Batch A) was added to 
200 µl mid log-phase cultures (104-105 cells) of S. aureus in synthetic wound fluid (SWF) and 
culture optical density measured over 18 hours’ incubation at 37°C. The means of four replica 
populations are shown, with the associated standard error (shaded intervals; too small to see for 
ES-O and ES-L). (B) 200 µl of ES-O or ES-L (batch A, filled circles and batch B, open circles) 
or the individual ingredient preparations was added to five one-day-old cultures of S. aureus  
growing at 37°C in a synthetic wound (400 µl synthetic wound fluid rendered semi-solid by add-
ing 2 mg ml-1 collagen). The control treatment was sterile distilled water left to stand for nine 
days in the presence of brass, which was present in all other preparations to simulate the pres-
ence of a copper alloy vessel (see Material & methods). After 24 hours’ further incubation, the 
collagen was dissolved to recover cells for agar plate counts.  
 
Figure 3. The activity of Bald’s eyesalve against S. aureus biofilms requires several ingredients. 
  
200 µl of the onion variant of the eyesalve (ESO) or the leek variant of the eyesalve (ESL) (batch 
C) or preparations missing a single ingredient, were added to three one-day-old cultures of S. au-
reus in synthetic wounds and bactericidal activity quantified as previously described. Red bars 
show the full or reduced versions of ESO, blue bars show the full or reduced versions of ESL 
and the green bar shows a variant of the eyesalve with neither onion nor leek (ES). The control 
treatment (grey bar) was sterile distilled water. Individual ingredients are coded as O = onion, L 
= leek, X = oxgall, W = wine, G = garlic and B = brass. Reduced recipes were assessed as having 
full (F), partial (P) or no (N) activity using contrasts versus the control treatment and the appro-
priate complete recipe.  
 
Figure 4. The activity of Bald’s eyesalve against S. aureus biofilms requires the nine-day wait-
ing period specified by the recipe. Immediately after preparation, 200 µl of the onion variant of 
the eyesalve (ES-O), the leek variant of the eyesalve (ES-L) (Batch D) or sterile distilled water 
was added to five one-day-old cultures of S. aureus growing at 37°C in a synthetic wounds and 
its bactericidal activity quantified as previously described (filled bars); the experiment was re-
peated using ES-O, ES-L (Batch D) after the nine-day waiting period specified by Bald (open 
bars). Asterisks denote treatments that were significantly different from the control. While the 
control cultures for the nine-day experiment grew to slightly lower densities than the control for 
the fresh eyesalve (p = 0.005), this difference was small compared with the differences observed 
for ES-O and ES-L (1-2 log vs. 4-5 log difference). 
 
Figure 5. Bactericidal activity of Bald's eyesalve in a mouse chronic wound model of MRSA 
infection. Six adult female Swiss Webster mice were administered wounds and infected with 
c.105 CFU S. aureus Mu50. Four days post-infection, mice were euthanised. Wound tissue was 
extracted and cut into either three (n = 3 mice) or four (n = 3 mice) equal pieces, which were 
weighed, submerged in 300 µl sterile saline (one replicate from n = 6 mice), 100µg ml-1 vanco-
mycin (one replicate from n = 3 mice), the onion variant of the eyesalve (ES-O; one replicate 
from n = 6 mice) or the leek variant of the eyeslve (ES-L; one replicate from n = 6 mice) (both 
ES-O and ES-L from Batch B) for four hours, then rinsed in sterile saline and homogenised. Vi-
able bacteria were enumerated and this number standardised per gram of tissue. Asterisk denotes 
treatments that were significantly different from the control. 
 
 
Figure S1. Bald’s eyesalve retains anti-Staphylococcal activity over thirty days of storage. The 
onion (ES-O) and leek (ES-L) variants of the recipes (Batches A and B) retained bactericidal ac-
tivity against S. aureus biofilms in synthetic wounds after 30 days of storage. (ANOVA: treat-
ment F2,24 = 217, p < 0.01; batch F1,24 = 0.16, p = 0.693; interaction F2,24 = 0.196, p = 0.823).  
 
Figure S2. Bald’s eyesalve kills MRSA in a mouse chronic wound infection. Adult female Swiss 
Webster mice were administered wounds and infected with c.105 CFU S. aureus Mu50. Four 
days post-infection, mice were euthanised. Wound tissue was extracted and cut into three equal 
pieces, which were weighed, submerged in 300 µl sterile saline, ES-O or ES-L (Batches A and 
B, after three months of storage at 4°C) for four hours, then rinsed in sterile saline and homoge-
nised. Viable bacteria were enumerated by plating. ES-L, but not ES-O, killed MRSA in wounds 
(ANOVA treatment F2,12 = 6.17, p = 0.014; post-hoc Tukey tests versus control ES-O p = 0.069, 
ES-L p = 0.014). There was no effect of eyesalve batch (batch F1,12 = 0.443, p = 0.518; interac-
  
tion F2,12 = 0.583, p = 0.573). The graph shows the mean of data from six mice per treatment 
(three for each batch of the eyesalve). 
 
Data S1. Bacterial species cultured from recipes and ingredient preparations. 
 
 
 
 
 
 





